Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1983-11-16
1986-04-15
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
2601125R, A61K 3700, C07C10352
Patent
active
045828210
ABSTRACT:
Peptide and amino acid halomethyl ketones are employed in processes for inhibiting cyclic nucleotide independent protein kinase activity and tumor cell growth.
REFERENCES:
Journal of Medicinal Chem. 1977, vol. 20, 452 and 453.
J. Med. Chem. 1980, 23, 275-278.
Biochemistry 1982, 21 6138-6144.
Biochimica et Biophysica Acta 601, 1980, 640-653.
Blaha, et al., "Peptides" (1982) 617-622.
Enzyme Systems Products (1981).
Biochimica et Biophys. Acta 480 (1977) 246-261.
Chemistry and Biochem. of Amino Acid Peptides and Proteins, vol. 4, (1971) Chapter 3.
Sefton, et al., Cell 20:807 (1980).
Hunter, TIBS 7:246 (1982).
Erikson, et al., J. Cell. Biol. 87:319 (1980).
Kasuga, et al., Proc. Nat. Acad. Sci. USA 80:2137 (1983).
Cohen, et al., J. Biol. Chem. 255:4834 (1980).
Erikson, et al., J. Biol. Chem. 256:11381 (1981).
Richert, et al., Cell 18:369 (1979).
Weber, Cell 5:253 (1975).
Johnson, et al., Biochemistry 21:2984 (1982).
Sajadi, et al., J. Med. Chem. 23:275 (1980).
Navarro, et al., Biochemistry 21:6138 (1982).
Kettner Charles A.
Racker Efraim
E. I. Du Pont de Nemours and Company
Phillips Delbert R.
LandOfFree
Inhibition of cyclic nucleotide independent protein kinases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of cyclic nucleotide independent protein kinases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of cyclic nucleotide independent protein kinases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1439062